Research Papers

25 of 227 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi …
Gold R; Barnett M; Chan A; Feng H; Fujihara K; Giovannoni G; Montalbán X; Shi FD; Tintoré M; Xue Q; Yang C; Zhou H.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4.
Centonze D; Amato MP; Brescia Morra V; Cocco E; De Stefano N; Gasperini C; Gallo P; Pozzilli C; Trojano M; Filippi M.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Cardiac therapies for Duchenne muscular dystrophy.
Shah MNA; Yokota T.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Lexical and syntactic deficits analyzed via automated natural language processing: the new monitoring tool in multiple …
Šubert M; Novotný M; Tykalová T; Srpová B; Friedová L; Uher T; Horáková D; Rusz J.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Arterial stiffness and its influence on cerebral morphology and cognitive function.
Haidegger M; Lindenbeck S; Hofer E; Rodler C; Zweiker R; Perl S; Pirpamer L; Kneihsl M; Fandler-Höfler S; Gattringer T; Enzinger C; Schmidt R.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Autonomic dysfunction entwined with post-COVID but absent in non-post-COVID patients: a neurophysiological and neuroson…
Papadopoulou M; Bakola E; Papapostolou A; Stefanou MI; Andreadou E; Zouvelou V; Stefanatou M; Gaga M; Michopoulos I; Tsivgoulis G.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Flow diversion for posterior circulation aneurysms: a multicenter retrospective study.
Qi P; Tong X; Liang X; Xue X; Wu Z; Feng X; Zhang M; Jiang Z; Wang D; Liu A.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Acceptance, drivers, and barriers to use eHealth interventions in patients with post-COVID-19 syndrome for management o…
Schröder J; Bäuerle A; Jahre LM; Skoda EM; Stettner M; Kleinschnitz C; Teufel M; Dinse H.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Impact of prehospital stroke triage implementation on patients with intracerebral hemorrhage.
Almqvist T; Falk Delgado A; Sjöstrand C; Ahmed N; Berglund A; Eriksson E; Mazya MV.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Comment on 'The overlapping relationship among depression, anxiety, and somatic symptom disorder and its impact on the …
Grzegorzewska AM; Wiglusz MS; Cubała WJ.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Locked-in syndrome revisited.
Schnetzer L; McCoy M; Bergmann J; Kunz A; Leis S; Trinka E.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Retrospective cohort study to devise a treatment decision score predicting adverse 24-month radiological activity in ea…
Hapfelmeier A; On BI; Mühlau M; Kirschke JS; Berthele A; Gasperi C; Mansmann U; Wuschek A; Bussas M; Boeker M; Bayas A; Senel M; Havla J; Kowarik MC; Kuhn K; Gatz I; Spengler H; Wiestler B; Grundl L; Sepp D; Hemmer B.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Therapeutic efficacy and safety of plasmapheresis in elderly patients with neuromyelitis optica spectrum disorder: a si…
Zhang W; Jiao Y; Cui L; Zhang Y; Jiao J; Jin M; Yuan W; You Y; Wang R; Peng D.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Longitudinal developmental profile of newborns and toddlers treated for spinal muscular atrophy.
Ngawa M; Dal Farra F; Marinescu AD; Servais L.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Evaluation of frequency, severity, and independent risk factors for recurrence of disease activity after fingolimod dis…
Cerdá-Fuertes N; Nagy S; Schaedelin S; Sinnecker T; Ruberte E; Papadopoulou A; Würfel J; Kuhle J; Yaldizli Ö; Kappos L; Derfuss T; Décard BF.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis.
Callegari I; Schneider M; Aebischer V; Voortman MM; Proschmann U; Ziemssen T; Lindberg R; Fischer-Barnicol B; Khalil M; Kappos L; Kuhle J; Sanderson NSR; Derfuss T.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Healthcare resource use in myasthenia gravis: a US health claims analysis.
Mahic M; Bozorg A; Rudnik J; Zaremba P; Scowcroft A.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Early neurological deterioration in patients with acute ischemic stroke: a prospective multicenter cohort study.
Liu H; Liu K; Zhang K; Zong C; Yang H; Li Y; Li S; Wang X; Zhao J; Xia Z; Song B; Xu X; Gao Y.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis - a review of population-spec…
Bayas A; Christ M; Faissner S; Klehmet J; Pul R; Skripuletz T; Meuth SG.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Intraplaque neovascularisation is associated with ischaemic events after carotid artery stenting: an observational pros…
Cui L; Xing Y; Wang L; Chen H; Chen Y.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy?
Kohle F; Dalakas MC; Lehmann HC.
Ther Adv Neurol Disord (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Vigabatrin-associated brain abnormalities on MRI in tuberous sclerosis complex patients with infantile spasms: are they…
Wan L; He W; Wang YY; Xu Y; Lu Q; Zhang MN; Wang QH; Dun S; Liu LY; Shi XY; Wang J; Hu LY; Zhang B; Yang G; Zou LP.
Ther Adv Neurol Disord (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Effectiveness of vagus nerve stimulation therapy in refractory hypoxic-ischemic encephalopathy-induced epilepsy.
Guo M; Wang J; Tang C; Deng J; Zhang J; Xiong Z; Liu S; Guan Y; Zhou J; Zhai F; Luan G; Li T.
Ther Adv Neurol Disord (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Comparative effectiveness of natalizumab <i>versus</i> ocrelizumab in multiple sclerosis: a real-world propensity score…
Pape K; Rolfes L; Steffen F; Muthuraman M; Korsen M; Meuth SG; Zipp F; Bittner S.
Ther Adv Neurol Disord (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The overlapping relationship among depression, anxiety, and somatic symptom disorder and its impact on the quality of l…
Shen S; Dong Z; Zhang Q; Xiao J; Zhou D; Li J.
Ther Adv Neurol Disord (Unknown)
Published: 2022
3/6 Transparent
Funding Declared